![Jessie English](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jessie English
No open positions remaining
Profile
Former jobs of Jessie M.
English include being a Senior Director at IRBM SpA and Merck Research Laboratories Massachusetts LLC from 2008 to 2010.
Dr. English also served as an Independent Director at Sensei Biotherapeutics, Inc. from 2021 to 2024 and as the Chief Scientific Officer at Tilos Therapeutics, Inc. from 2018 to 2019.
Additionally, Dr. English held the position of Head-Research at Belfer Center for Applied Cancer Science.
Other former positions include Vice President-Kinase Biology at ArQule, Inc. from 2010 to 2011 and VP & Head-Discovery Research at EMD Serono, Inc. from 2016 to 2018.
Furthermore, Dr. English served as the Chief Scientific Officer at Bakx Therapeutics, Inc. from 2020 to 2022.
Education history of Dr. English includes an undergraduate degree from Kansas State University and a doctorate degree from The University of North Carolina at Chapel Hill.
Former positions of Jessie English
| Companies | Position | End |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Director/Board Member | 01/07/2024 |
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Chief Tech/Sci/R&D Officer | 01/11/2022 |
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Chief Tech/Sci/R&D Officer | 01/11/2019 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01/01/2018 |
| ARQULE, INC. | Corporate Officer/Principal | 01/01/2011 |
Training of Jessie English
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
27
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Kansas State University
 Kansas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
IRBM SpA
 IRBM SpA BiotechnologyHealth Technology Researches and develops new drugs | Health Technology |
Tilos Therapeutics, Inc.
Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Health Technology |
Belfer Center for Applied Cancer Science
 Belfer Center for Applied Cancer Science Miscellaneous Commercial ServicesCommercial Services Operates cancer research center | Commercial Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Jessie English
